Consolidated Income Statement (*)

(€ million)Note20132012 (**)
Net revenues  (1) 86,816 83,957
Cost of sales (2) 74,57 71,701
Selling, general and administrative costs (3) 6,689 6,763
Research and development costs (4) 2,231 1,85
Other income/(expenses)   68 -102
TRADING PROFIT/(LOSS)   3,394 3,541
Result from investments: (5) 97 107
Share of the profit/(loss) of investees accounted for using the equity method   87 94
Other income/(expenses) from investments   10 13
Gains/(losses) on the disposal of investments (6) 8 (91)
Restructuring costs (7) 28 15
Other unusual income/(expenses) (8) (499) (138)
EBIT   2,972 3,404
Financial income/(expenses) (9) (1,964) (1,885)
PROFIT/(LOSS) BEFORE TAXES   1,008 1,519
Tax (income)/expenses (10) (943) 623
PROFIT/(LOSS) FROM CONTINUING OPERATIONS   1,951 896
Profit/(loss) from Discontinued Operations   - -
PROFIT/(LOSS)   1,951 896
       
PROFIT/(LOSS) ATTRIBUTABLE TO:      
Owners of the parent   904 44
Non-controlling interests   1,047 852
       
(in €)      
BASIC EARNINGS/(LOSS) PER ORDINARY SHARE (12) 0.744 0.036
DILUTED EARNINGS/(LOSS) PER ORDINARY SHARE (12) 0.736 0.036

(*) Pursuant to Consob Resolution 15519 of 27 July 2006, the effects of related party transactions on the consolidated income statement are presented in the specific Income Statement schedule provided in the following pages and are further described in Note 31.

(**) Following the retrospective application of the amendment to IAS 19 from 1 January 2013, the 2012 comparative amounts were restated as required by IAS 1. Compared to the previously reported figures, Profit for 2012 decreased by €515 million, of which mainly €273 million in Trading Profit/EBIT and €244 million in Financial expenses. Reference should be made to the section "New and revised IFRSs adopted since 1 January 2013" for further details.